BioInvent

Sweden
Lund, Skane Lan, Sweden
+46 46 286 85 50 ★

Company profile

BioInvent company profile

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs targeting cancers with unmet clinical need.Our drug development programmes are supported by our human antibody development platform. This consists of a proprietary antibody library, n-CoDeR:registered:, and in-house technology for the rapid selection, screening and identification of antibodies with excellent affinity and selectivity for targets. BioInvent has a high level of competence in antibody drug discovery, preclinical and clinical development. The Company also has many years' experience in process development and antibody manufacturing, which we carry out at our own facilities. Alongside our in house and partnered drug-development programmes we offer..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
+46 46 286 85 50
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$10K+
Founded
1983-01-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
2
Total equity funding
$5.4M
Last funding
Post Ipo Equity / $3M / 2023-04-26
Last equity funding
Post Ipo Equity / $3M
Investors
1
Articles
109
Exited on
2004-10-08

Founders and investors

Investors

Blood Cancer United, Inc.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.